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TO THE EDITOR
Autotaxin (ATX) has enzymatic lyso-
phospholipase D activity and hydro-
lyzes lysophosphatidylcholine into
lysophosphatidic acid (LPA). ATX is
widely expressed, with the highest
mRNA levels detected in adipose tissue,
brain, placenta, ovary, and small intes-
tine. ATX-LPA signaling is important
in physiological and pathological pro-
cesses, from vascular and neural devel-
opment to lymphocyte homing, fibrosis,
and cancer (Moolenaar and Perrakis,
2011). Recently, serum ATX levels
were reported to correlate with pruritus
of cholestasis (Kremer et al., 2012).
Atopic dermatitis (AD) is a major pruri-
tic inflammatory skin disease. Scratching
behavior from intensive itching results
in skin barrier dysfunction and exacer-
bation of AD (Barnes, 2010). Severe
pruritus in AD has been attributed to
increased release of substance P, nerve
growth factor, neurotrophin-3 and 4,
brain-derived neurotrophic factor and
histamine (Arck and Paus, 2006).
Newly identified itch mediators include
the histamine 4 receptor, interleukin-31,
and Toll-like receptor 3 (Liu et al., 2012).
In this study, we measured serum ATX
levels in AD patients and examined
whether they could be an index marker
of pruritus in AD.
Thirty-one AD patients (mean±SEM
age: 30.0±2.0 years, 20 men and 11
women) and 28 healthy controls (28.8±
1.7 years, 10 men and 18 women) were
enrolled in this study. All AD patients
were given diagnoses according to the
criteria of Hanifin and Rajka (1980). The
disease severity was determined by
Physician Global Assessment and the
Eczema Area and Severity Index (EASI).
We rated itch by visual analog scale
(VAS) 0–10, asking the patients to mark
a point on the line corresponding
to mean itch during the last 7 days.
The medical ethical committee of the
University of Tokyo approved all des-
cribed studies, and the study was con-
ducted according to the Declaration of
Helsinki Principles. Written informed
consent was obtained from participants.
The 28 healthy controls had no history
of allergic diseases such AD, allergic
rhinitis, or asthma. All AD patients
were treated with topical medication
and/or antihistamine drugs. We exclu-
ded patients treated with oral steroid or
cyclosporine because they would affect
serum ATX levels (Sumida et al., 2013).
Enzyme immunoassay was performed
using Quantikine Human ENPP-2/
Autotaxin ELISA kit (R&D systems,
Minneapolis, MN). Statistical analysis
was performed using the Mann–
Whitney’s U-test for comparison of two
groups. Correlation coefficients were
determined by using the Spearman’s
rank correlation test. P-values ofo0.05
were considered statistically significant.
Serum ATX levels in AD patients
were significantly higher than those in
healthy individuals (74.8±12.3 and
32.9±5.9pgml1, respectively; Po0.01,
Figure 1a). As ATX levels were reported
to be higher in females than in males
(Nakamura et al., 2008), we analyzed
serum ATX levels according to their sex.
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Figure 1. Serum autotaxin levels in atopic dermatitis (AD) and healthy controls. (a) Serum autotaxin
levels in 31 AD patients and 28 healthy individuals. Each bar indicates the mean of the group. (b) Serum
autotaxin levels in males and females. (c) Serum autotaxin levels in different age groups. *Po0.05 and
**Po0.01.
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Serum ATX levels in male AD patients
were 43.1±6.9 pg ml 1, which were
significantly higher than those in healthy
male controls (24.9±7.4 pg ml1,
Po0.05, Figure 1b). Similar results were
obtained between female AD patients
and female healthy controls (132.3±
24.4 pg ml1 vs. 37.3±8.1 pg ml1,
Po0.01, Figure 1b). Serum ATX levels
in female AD patients were significantly
elevated than those in male AD patients
(Po0.01). Moreover, we analyzed
serum ATX levels according to their
age. In the twenties, serum ATX levels
in AD patients were significantly higher
than those in healthy controls (97.0±
23.4 and 37.2±8.9 pg ml1, respec-
tively; Po0.05, Figure 1c). In the thir-
ties, AD patients exhibited significantly
higher serum ATX levels compared with
healthy controls (67.1±25.1 and 24.8±
12.2 pg ml1, respectively; Po0.01,
Figure 1c), whereas in the forties, there
was no significant difference between
AD patients and healthy controls. In the
teens, serum ATX levels in AD patients
tended to be higher than those in
healthy controls (118±30.2 and 57.5±
2.22 pg ml1, respectively), although
difference did not reach statistical sig-
nificance. Serum ATX levels in AD
patients decreased as they grew older,
which might be associated with the
improvement of the disease activity of
AD by age. We also analyzed serum
ATX levels according to the severity of
AD; serum ATX levels were elevated as
the disease severity increased (Figure
2a). Moreover, serum ATX levels signifi-
cantly correlated with EASI (r¼0.43,
Po0.05, Figure 2b) and decreased after
treatment (Po0.05, Figure 2c). We next
examined the correlation between serum
ATX levels and VAS itch scores or other
serum markers reflecting the disease
activity of AD, such as IgE and CCL17.
Serum ATX levels significantly correlated
with VAS itch scores (r¼0.44, Po0.05,
Figure 2d), but not with serum IgE or
CCL17 levels (data not shown).
Our study revealed that serum ATX
levels in AD patients were significantly
higher than healthy individuals and that
serum ATX levels significantly correlated
with EASI, a widely used quantitative
evaluation of AD severity. Furthermore,
serum ATX levels in each patient signi-
ficantly decreased after treatment. As
the patients in this study were under
treatment, we cannot deny the possibility
that topical steroids had influenced
serum ATX levels as reported with oral
steroid treatment (Sumida et al., 2013).
Interestingly, serum ATX levels correla-
ted with VAS itch scores. Neuropeptides
such as calcitonin gene-related peptide,
substance P, gastrin-releasing peptide
as well as nerve growth factor have
been reported to have critical roles in
the itch signaling pathways (Kagami
et al., 2013; Yarbrough et al., 2013).
Recent research shows that ATX is
expressed in several human organs and
correlates with the pruritus of cholestasis
(Kremer et al., 2012). ATX expression
is elevated in reactive astrocytes adjacent
to sites of neurotrauma, having a role in
neuropathic pain (van Meeteren and
Moolenaar, 2007; Nakanaga et al., 2010;
Okudaira et al., 2010). In oligodendrocyte
precursors before myelination, ATX pro-
motes process branching and focal adhe-
sion organization (van Meeteren et al.,
2006). Taken together, ATX is essential
for neural development and might be
associated with neurophysiological itch
pathways. Our study revealed that serum
ATX levels correlated with pruritus in
AD, suggesting that ATX could be a
therapeutic target for pruritus in AD.
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Figure 2. Correlation between serum autotaxin levels and the disease markers of atopic dermatitis (AD).
(a) Serum autotaxin levels in AD patients according to the disease severity. (b) Serum autotaxin levels
significantly correlated with Eczema Area and Severity Index (EASI) scores. (c) Serum autotaxin levels
significantly decreased after treatment. (d) Serum autotaxin levels significantly correlated with visual analog
scale (VAS) itch scores.
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TO THE EDITOR
Early onset of psoriasis makes the under-
standing of pregnancy outcomes in
patients with psoriasis important. Studies
have shown that psoriasis is a risk factor
for adverse pregnancy outcomes (Cohen-
Barak et al., 2010; Yang et al., 2010) and
that pregnant women with psoriasis
are more likely to be depressed, obese,
and to smoke compared with women
without psoriasis (Bandoli et al., 2010).
Psoriasis shares pathological mecha-
nisms with other chronic inflammatory
diseases. Studies have demonstrated that
women with Crohn’s disease have an
increased risk of spontaneous abor-
tion (Malgarinos et al., 2007) and that
women with rheumatoid arthritis have
prolonged time to pregnancy (TTP)
(Jawaheer et al., 2011), and therefore
we wanted to determine whether
women with psoriasis are at increased
risk of fetal death and prolonged TTP.
We used data from the Danish
National Birth Cohort (DNBC),
containing information on 100,418
pregnancies enrolled from 1996–2003.
Information regarding reproductive his-
tory, lifestyle during pregnancy and
demographic characteristics was
obtained from telephone interviews.
Information regarding psoriasis was
self-reported. Data on pregnancy out-
comes were obtained from linkage with
the Danish National Patient Registry
(Lynge et al., 2011) and from the Civil
Registration System (Pedersen, 2011).
Details of the cohort and its structure
are given elsewhere (Olsen et al., 2001).
In all, 87,692 pregnancies were
eligible for the analysis of fetal death
(Supplementary Figure S1 online). Preg-
nancies eligible for analysis of TTP were
restricted to first-time pregnancies, to
avoid dependency between observa-
tions, resulting in 81,627 pregnancies.
Of the 87,692 pregnancies included
2,553 (3%) were of women with
psoriasis. Characteristics of the study
population are presented in Table 1
and Supplementary Table S1 online.
Compared to women without psoriasis,
women with psoriasis more often
smoked during pregnancy. Women with
psoriasis were older, and were more
often overweight with a body mass
index (BMI) of X25 (WHO, 2013).
Fetal death included spontaneous
abortions, stillbirths and twin births
in which one or both babies had died.
We analyzed the association between
psoriasis and fetal death using Cox
proportional hazards regression models,
giving hazard ratios (HRs) with 95%
confidence intervals (CIs). Analyses
were run with delayed entry and gesta-
tional age as the underlying time scale.
We took into account that some
women contributed with more than
one pregnancy, by including a robust
sandwich variance estimator handling
the within-person correlation between
pregnancies. Of the 2,553 pregnancies
in women with psoriasis, 36 (1.4%)
ended in fetal death compared with
1,119 (1.3%) fetal deaths in women
without psoriasis. This translated to a
HR of 1.05 (95% CI 0.75–1.46) after
adjustment (Table 2).Accepted article preview online 24 January 2014; published online 20 February 2014
Abbreviations: BMI, body mass index; DNCB, the Danish National Birth Cohort; TTP, time to pregnancy
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